Outpatient pediatric community - Acquired methicillin-resistant Staphybcoccus aureus: A polymorphous clinical disease

Cutis

Volumn 81, Issue 2, 2008, Pages 115-122

  Groner, Abraham ^a   Laing Grayman, Deborah ^b,c,d   Silverberg, Nanette B ^b,c,d,e  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d College of Physicians and Surgeons ^*  (United States)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ARTICLE; CASE REPORT; CHILD; COMMUNICABLE DISEASE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INFANT; MALE; PENICILLIN RESISTANCE; PRESCHOOL CHILD; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT; MALE; METHICILLIN RESISTANCE; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 41149105847     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ochoa TJ, Mohr J, Wanger A, et al. Community-associated methicillin-resistant Staphylococcus aureus in pediatric patients. Emerg Infect Dis. 2005;11:966-968.
2. Darmstadt G, Galen WK, Fischer G. Bacterial infections. In: Schachner LA, Hansen RC, eds. Pediatric Dermatology. 3rd ed. Edinburgh, Scotland: Mosby; 2003:989-1000.
3. Darsow U, Lubbe J, Taieb A, et al. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol. 2005;19:286-295.
4. Buescher ES. Community-acquired methicillin-resistant Staphylococcus aureus in pediatrics. Curr Opin Pediatr. 2005;17:67-70.
5. Marcinak JF, Frank AL. Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children. Curr Opin Infect Dis. 2003;16:265-269.
6. Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002;359:1819-1827.
7. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol. 1974;90:525-530.
8. Ricci G, Patrizi A, Neri I, et al. Frequency and clinical role of Staphylococcus aureus overinfection in atopic dermatitis in children. Pediatr Dermatol. 2003;20:389-392.
9. Benenson S, Zimhony O, Dahan D, et al. Atopic dermatitis - a risk factor for invasive Staphylococcus aureus infection: two cases and review. Am J Med. 2005;118:1048-1051.
10. Akiyama H, Yamasaki O, Tada J, et al. Adherence characteristics and susceptibility to antimicrobial agents of Staphylococcus aureus strains isolated from skin infections and atopic dermatitis. J Dermatol Sci. 2000;23: 155-160.
11. Shopsin B, Mathema B, Martinez J, et al. Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. J Infect Dis. 2000;182:359-362. Epub July 6, 2000.
12. Langley JM, Soder CM, Schlievert PM, et al. Case report: molluscum contagiosu., toxic shock syndrome following cantharidin treatment. Con Fam Physician. 2003;49:887-889.
13. Paul C, Cork M, Rossi AB, et al. Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years. Pediatrics. 2006;117:118-128. Epub December 15, 2005.
14. Park CW, Lee BH, Lee CH. Tacrolimus reduces staphylococcal colonization on the skin of Korean atopic dermatitis patients. Drugs Exp Clin Res. 2005;31:77-87.
15. Leyden JJ, Kligman AM. The case for steroid - antibiotic ' combinations. Br/Dermatol. 1977;96:179-187.
16. Lever R, Hadley K, Downey D, et al. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol. 1988;119:189-198.
17. Ewing C, Ashcroft C, Gibbs A. Flucloxacillin in the ] treatment of atopic dermatitis. Br J Dermatol. 1998;138: 1022-1029.
18. Sandri AM, Dalarosa MG, Ruschel de Alcantara L, et al. Reduction in incidence of nosocomial methicillinresistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol. 2006;27:185-187. Epub February 8, 2006.
19. Kampf G, Kramer A. Eradication of methicillinresistant Staphylococcus aureus with an antiseptic soap and nasal mupirocin among colonized patients-an open uncontrolled clinical trial. Ann Clin Microbiol Antimicrob. 2004;3:9.
20. Naimi TS, LeDeIl KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976-2984.
21. Frazee BW, Lynn J, Charlebois ED, et al. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med. 2005;45:311-320.
22. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin- resistant Staphylococcus aureus. Pediatr Infect Dis J. 2004;23:123-127.
23. Gosbell IB. Methicillin-resistant Staphylococcus aureus: impact on dermatology practice. Am J Clin Dermatol. 2004;5:239-259.